Logos Global Management »

Lb Pharmaceuticals shares owned by Logos Global Management

Quarter-by-quarter ownership of Lb Pharmaceuticals shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Logos Global Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $18M 1.1M 15.79

More positions owned by Logos Global Management

Revolution Medicines Call Option (RVMD)
Ideaya Biosciences Call Option (IDYA)
Akero Therapeutics (AKRO)
Arvinas Ord (ARVN)
Ocular Therapeutix (OCUL)
Cidara Therapeutics Com New (CDTX)
Verastem Com New (VSTM)
Abivax Sa Sponsored Ads (ABVX)
Janux Therapeutics (JANX)
Erasca (ERAS)
Maze Therapeatics (MAZE)
Olema Pharmaceuticals (OLMA)
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Disc Medicine (IRON)

View all positions for Logos Global Management

Top funds holding Lb Pharmaceuticals

Deep Track Capital
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Jpmorgan Chase & Co
BlackRock
Balyasny Asset Management
Vivo Capital
Jennison Associates
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management
Soleus Capital Management

View all funds holding Lb Pharmaceuticals